Literature DB >> 7616403

Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.

S M Florin1, R Kuczenski, D S Segal.   

Abstract

Following reserpine pretreatment to disrupt vesicular stores of dopamine and norepinephrine, in vivo microdialysis was used in behaving rats to evaluate the role of vesicles in the neurochemical and behavioral responses to amphetamine and cocaine. Reserpine (2.5 mg/kg, 24 hr) completely prevented the hippocampus norepinephrine responses to 20 mg/kg of cocaine and to 0.5, 1.25 and 5.0 mg/kg of amphetamine. Likewise, reserpine almost completely abolished the caudate putamen dopamine response to cocaine. In contrast, the effect of reserpine on the amphetamine-induced dopamine response varied as a function of amphetamine dose. Although the dopamine response to 1.25 mg/kg of amphetamine was unchanged by reserpine pretreatment, the dopamine responses to both the lowest (0.5 mg/kg) and highest (5.0 mg/kg) doses of amphetamine were significantly attenuated by about 65% and 50%, respectively. These results indicate that the norepinephrine response to amphetamine is dependent on vesicular stores of transmitter at all doses of the drug. However, although amphetamine can release dopamine from a reserpine-resistant (non-vesicular) pool, it also appears that this response partially depends on vesicular stores, especially at low and high doses of drug. Concomitant behavioral assessments revealed that the behavioral responses to cocaine and the lowest dose of amphetamine, like the dopamine responses, were significantly suppressed by reserpine pretreatment. In contrast, at the intermediate dose of amphetamine, stereotypies were significantly enhanced. These altered behavioral profiles are discussed in terms of a balance between increases in both dopamine and norepinephrine produced by amphetamine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616403

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levels.

Authors:  Stephen J Kohut; Kathleen L Decicco-Skinner; Shirin Johari; Zachary E Hurwitz; Michael H Baumann; Anthony L Riley
Journal:  Neuropharmacology       Date:  2012-03-23       Impact factor: 5.250

Review 2.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

Authors:  Louis J De Felice; Richard A Glennon; Sidney S Negus
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

3.  Neuropharmacological characterization of local ibogaine effects on dopamine release.

Authors:  M S Reid; K Hsu; K H Souza; P A Broderick; S P Berger
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation.

Authors:  E J Hess; K A Collins; M C Wilson
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

5.  Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.

Authors:  Martine C J van der Elst; Yvette S Wunderink; Bart A Ellenbroek; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

6.  An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.

Authors:  D S Segal; R Kuczenski
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

7.  Effects of monoamine depletion on the ketamine-induced locomotor activity of preweanling, adolescent, and adult rats: Sex and age differences.

Authors:  Cynthia A Crawford; Andrea E Moran; Timothy J Baum; Matthew G Apodaca; Nazaret R Montejano; Ginny I Park; Vanessa Gomez; Sanders A McDougall
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

8.  Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex.

Authors:  James R Shoblock; Isabelle M Maisonneuve; Stanley D Glick
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

Review 9.  Norepinephrine at the nexus of arousal, motivation and relapse.

Authors:  Rodrigo A España; Brooke E Schmeichel; Craig W Berridge
Journal:  Brain Res       Date:  2016-01-07       Impact factor: 3.252

10.  Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys.

Authors:  Paul W Czoty; Alexandros Makriyannis; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.